Histoplasmosis News and Research

RSS
Histoplasmosis is an infectious condition caused by the fungus Histoplasma capsulatum. It is caused when the spores of the fungus are inhaled into the lungs. The lungs are the primary infection site.
Climate change heats up fungal threats worldwide

Climate change heats up fungal threats worldwide

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Increased distribution of fungal infections throughout the U.S.

Increased distribution of fungal infections throughout the U.S.

False positive monkeypox tests in low-risk patients with no exposures

False positive monkeypox tests in low-risk patients with no exposures

Study reveals infections by Histoplasma fungus as major cause of death in people with HIV

Study reveals infections by Histoplasma fungus as major cause of death in people with HIV

Rare pulmonary disease discovered in rural Alberta

Rare pulmonary disease discovered in rural Alberta

ATS publishes clinical guideline on laboratory diagnosis of fungal infections

ATS publishes clinical guideline on laboratory diagnosis of fungal infections

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

Using a health information exchange network to enhance disease surveillance

Using a health information exchange network to enhance disease surveillance

Which animal is most likely to spread the latest plague?

Which animal is most likely to spread the latest plague?

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Recent estimates reveal burden of serious fungal diseases in 14 different countries

Recent estimates reveal burden of serious fungal diseases in 14 different countries

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Inflectra (infliximab-dyyb) approved for multiple indications

Inflectra (infliximab-dyyb) approved for multiple indications

New diagnostic criteria can help distinguish malignant cancerous chest cavity masses from histoplasmosis

New diagnostic criteria can help distinguish malignant cancerous chest cavity masses from histoplasmosis

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

MSD announces EC approval of SIMPONI (golimumab) for treatment of adult patients with nr-axial SpA

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.